Kerr BM - Search Results

1

Delavirdine: clinical pharmacokinetics and drug interactions.

Tran JQ, Gerber JG, Kerr BM. Tran JQ, et al. Among authors: kerr bm. Clin Pharmacokinet. 2001;40(3):207-26. doi: 10.2165/00003088-200140030-00005. Clin Pharmacokinet. 2001. PMID: 11327199 Review.

2

Pharmacokinetic interaction between amprenavir and delavirdine: evidence of induced clearance by amprenavir.

Tran JQ, Petersen C, Garrett M, Hee B, Kerr BM. Tran JQ, et al. Among authors: kerr bm. Clin Pharmacol Ther. 2002 Dec;72(6):615-26. doi: 10.1067/mcp.2002.128868. Clin Pharmacol Ther. 2002. PMID: 12496743 Clinical Trial.

3

Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin.

Hsyu PH, Schultz-Smith MD, Lillibridge JH, Lewis RH, Kerr BM. Hsyu PH, et al. Among authors: kerr bm. Antimicrob Agents Chemother. 2001 Dec;45(12):3445-50. doi: 10.1128/AAC.45.12.3445-3450.2001. Antimicrob Agents Chemother. 2001. PMID: 11709322 Free PMC article. Clinical Trial.

4

Pharmacokinetic interaction of nelfinavir and methadone in intravenous drug users.

Hsyu PH, Lillibridge J, Daniels E, Kerr BM. Hsyu PH, et al. Among authors: kerr bm. Biopharm Drug Dispos. 2006 Mar;27(2):61-8. doi: 10.1002/bdd.482. Biopharm Drug Dispos. 2006. PMID: 16299829 Clinical Trial.

5

Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers.

Hsyu PH, Pithavala YK, Gersten M, Penning CA, Kerr BM. Hsyu PH, et al. Among authors: kerr bm. Antimicrob Agents Chemother. 2002 Feb;46(2):392-7. doi: 10.1128/AAC.46.2.392-397.2002. Antimicrob Agents Chemother. 2002. PMID: 11796347 Free PMC article. Clinical Trial.

6

Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate.

Lillibridge JH, Liang BH, Kerr BM, Webber S, Quart B, Shetty BV, Lee CA. Lillibridge JH, et al. Among authors: kerr bm. Drug Metab Dispos. 1998 Jul;26(7):609-16. Drug Metab Dispos. 1998. PMID: 9660842

7

A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trial.

Jackson KA, Rosenbaum SE, Kerr BM, Pithavala YK, Yuen G, Dudley MN. Jackson KA, et al. Among authors: kerr bm. Antimicrob Agents Chemother. 2000 Jul;44(7):1832-7. doi: 10.1128/AAC.44.7.1832-1837.2000. Antimicrob Agents Chemother. 2000. PMID: 10858338 Free PMC article. Clinical Trial.

8

Metabolism and disposition of lesinurad, a uric acid reabsorption inhibitor, in humans.

Shah V, Yang C, Shen Z, Kerr BM, Tieu K, Wilson DM, Hall J, Gillen M, Lee CA. Shah V, et al. Among authors: kerr bm. Xenobiotica. 2019 Jul;49(7):811-822. doi: 10.1080/00498254.2018.1504257. Epub 2018 Sep 12. Xenobiotica. 2019. PMID: 30117757 Clinical Trial.

9

Supratherapeutic dose evaluation and effect of lesinurad on cardiac repolarization: a thorough QT/QTc study.

Shen Z, Gillen M, Tieu K, Nguyen M, Harmon E, Wilson DM, Kerr B, Lee CA. Shen Z, et al. Drug Des Devel Ther. 2016 Oct 27;10:3509-3517. doi: 10.2147/DDDT.S114455. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27826183 Free PMC article.

10

Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and CYP Enzyme Substrates Sildenafil, Amlodipine, Tolbutamide, and Repaglinide.

Gillen M, Yang C, Wilson D, Valdez S, Lee C, Kerr B, Shen Z. Gillen M, et al. Clin Pharmacol Drug Dev. 2017 Jul;6(4):363-376. doi: 10.1002/cpdd.324. Epub 2017 Jan 9. Clin Pharmacol Drug Dev. 2017. PMID: 28067999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters